In this interview, NewsMed talks to Dr. James Mencel's Guidance about Scaling Up API Processes. Could you introduce yourself and your experience in the pharmaceutical industry? I obtained a B.S. in ...

The track by which API manufacturing processes are prepared for commercial use is comparable to overlapping integrative process evaluations at commercial scale. This ensures the process is ...

Opportunities center on HPAPIs for oncology and rare diseases, biotech APIs for biologics and biosimilars, AI-enabled continuous manufacturing, greener production, and localized, diversified supply ...

Asahi Kasei’s Novel Forward Osmosis–Membrane Distillation System Installed at Peptistar's API Manufacturing Facility for Reduced Pharmaceutical Manufacturing Time Japanese pharmaceutical contract ...

New drug approvals, generic expansion, high-potency API demand, and the continued globalization of pharmaceutical manufacturing present lucrative business opportunities Small Molecule API ...

Gland Pharma Limited ("Gland Pharma") and Neuland Laboratories Limited ("Neuland") today announced a long-term strategic CDMO partnership. Under the partnership Gland will establish a sterile ...

Recently, demand for APIs has shifted from traditional, high-volume small molecules to a broader need across biologics, peptides, oligonucleotides, viral vectors, and more. API needs are becoming ...

TOKYO--(BUSINESS WIRE)--Japanese pharmaceutical contract development and manufacturing organization (CDMO) Peptistar has integrated Asahi Kasei’s novel forward osmosis–membrane distillation (FO–MD) ...